Health

JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a leading US medical institution and other organizations to harness technology for better patient care and outcomes in oncology. TAIPEI, Jan. 22, 2025 /PRNewswire/ -- JelloX

2025-01-22 15:29 205

Samsung Biologics reports fourth quarter and fiscal year 2024 financial results

* Recorded Q4'24 consolidated revenue of KRW 1.26 trillion * Recorded FY'24 consolidated revenue of KRW 4.55 trillion * Poised for further growth with expanded capacity and new service offerings INCHEON,South Korea, Jan. 22, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a globa...

2025-01-22 15:06 412

2025 Japan Prize Laureates Announced

TOKYO, Jan. 22, 2025 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2025 Japan prize onJanuary 22, 2025. Prof. Russell Dean Dupuis of theUSA has been awarded the Japan Prize in the fields of Materials Sciences and Production, and Prof.Carlos M. Duarte of Spain has been aw...

2025-01-22 15:00 188

Akeso Received Payment for the Development Collaboration on Tagitanlimab

HONG KONG, Jan. 22, 2025 /PRNewswire/ -- On January 22, 2025, Akeso Inc. (9926.HK) announced that it had received payment from Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. ("Sichuan Kelun") for their collaboration on the development of tagitanlimab, an innovative humanized monoclona...

2025-01-22 14:57 456

Hyundai ADM Unveils a "New Paradigm in Cancer Treatment" - Preclinical Study Shows Promise for Continuous Oral Chemotherapy with Lowered Side Effects Risks

SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ -- Hyundai ADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug OTX-M, developed from the well-known injectable chemotherapy drug docetaxel, at the "Biotech Showcase 2025" held ...

2025-01-22 14:43 504

Anbio Biotechnology to Showcase Cutting-Edge Diagnostic Solutions at 2025 Medlab Middle East

DUBAI, UAE , Jan. 21, 2025 /PRNewswire/ -- Anbio Biotechnology ("Anbio"), a global leader in in-vitro diagnostic technologies, is excited to announce its participation in the 2025 Medlab Middle East exhibition, taking place from 3rd to 6th February at theDubai World Trade Centre. The event is one...

2025-01-22 13:08 643

Science and Technology Daily: AI for a Better Life

BEIJING, Jan. 22, 2025 /PRNewswire/ -- As AI continues to evolve at an unprecedented pace, with breakthroughs in generative models, ethical guidelines, and applications across various sectors, the question is often asked — how will these advancements positively impact people's daily life?   Sci...

2025-01-22 12:20 889

Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers

HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement withArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug conjugate ("ADC") for the treatment of Gastrointesti...

2025-01-22 12:19 930

Antennova Presents Latest Phase I/II Data on ATN-022 in Advanced/Metastatic Gastric Cancer, Including an ORR of 42.9%, at ASCO GI 2025

BOSTON, Jan. 21, 2025 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and Australia evaluating ATN-022 (CLDN18.2 antibody-drug conjugate [ADC]) in patients with advance...

2025-01-22 11:01 952

Thailand to Showcase Medical and Wellness Excellence at Expo 2025 Osaka, Kansai, Japan

BANGKOK, Jan. 22, 2025 /PRNewswire/ -- Thailand is set to make a grand debut at Expo 2025 Osaka, Kansai,Japan, highlighting the country's commitment to becoming one of the global leaders in medical and wellness services. In line with the Expo's theme"Designing Future Society for Our Lives," Thail...

2025-01-22 10:30 1053

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

* ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity, supporting once-daily or less frequent oral dosing. * ASC30 oral tablet was generally safe and well ...

2025-01-21 19:00 2053

The BioCircular Materials Alliance initiated by Spiber welcomes new partners including Stella McCartney and publishes its first Progress Report

* Stella McCartney, Marzotto Wool Manufacturing Srl, Fashion for Good, and 13 new companies and organizations have joined the BioCircular Materials Alliance (the "Alliance"), led by biomaterials pioneer Spiber. * The Alliance published its first Progress Report, highlighting ongoing research ...

2025-01-21 18:00 2100

TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant

TAIPEI, Jan. 21, 2025 /PRNewswire/ -- TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving film (ODF). This trial was conducted following detailed discussions and alignment with the U.S. Food and Drug Admin...

2025-01-21 15:30 1261

Virtus Fertility Centre Singapore Marks a Decade of Fertility Care

Virtus Health's first greenfield embryology and andrology facility in Asia strives to stay at the forefront of reproductive medicine through science, ongoing research, evidence-based personalized care, and accessible fertility education. SINGAPORE, Jan. 21, 2025 /PRNewswire/ -- Virtus Fertility ...

2025-01-21 14:00 1355

YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia

SHANGHAI, Jan. 20, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial forYOLT-204, an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT i...

2025-01-21 10:34 1887

AXA and Prosper Health introduce pioneering dedicated cancer case management service in Greater Bay Area[1]

Partners with Prosper Health introducing "Greater Bay Area Cancer Medical Concierge Service Network" HONG KONG, Jan. 21, 2025 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA")  announces a partnership with Prosper Health, a member-centric health insurance service provider under New Frontier Group - ...

2025-01-21 10:23 2322

MedAdvisor Solutions' helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024

New case study showcases improved operational efficiency and patient care with enhanced workflow and clinical services for pharmacists MELBOURNE, Australia, Jan. 21, 2025 /PRNewswire/ -- MedAdvisor Solutions, a global leader in patient engagement and pharmacy technology, published its newest cas...

2025-01-21 07:22 1400

MicroAire Completes Acquisition of NEOSYAD

CHARLOTTESVILLE, Va., Jan. 21, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, the global leader in power-assisted liposuction, is pleased to announce the acquisition of NEOSYAD, an innovative medical device company that developed a breakthrough technology for adipose tissue engineering. Thi...

2025-01-21 01:00 1375

CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI, Jan. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that KJ-C2320, an allogeneic CAR T-cell therapy targeting CD38, has a...

2025-01-20 21:50 1913

SIRPAD - WORLD'S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT

TAMPA, Fla., Jan. 20, 2025 /PRNewswire/ -- Concept Medical Inc . (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the successful completion of patient enrolment in the SirPAD Trial, with over 1,250 pat...

2025-01-20 21:44 2298
12345 ... 873